3D Printing Medical Devices Market
Current Scenario
In recent years, 3D printing technology has advanced significantly. It enables enthusiasts, engineers, and designers to produce a diverse range of function end-use parts, prototypes, and models from a multitude of materials. As a result of a ground-breaking achievement by surgeons at the University of Texas Southwestern Medical Center (UT Southwestern) in collaboration with researchers from the University of Texas at Dallas (UTD), a 3D printed femur has been produced that has the potential to alter surgical preparation for bone procedures, in November 2024. Moreover, today, the United States is regarded as a leader in additive manufacturing. The USA remains at the top of the list as the nation with the maximum number of patents in 3D printing, with close to 40 per cent of international patent families registered between 2001 and 2020. This surpasses the share of European players, i.e. 6.9 per cent.
Drivers
The growth of the 3D printing medical devices market is driven by technological advancements and customization. A major advantage of additive manufacturing in healthcare is its capacity to produce tailored medical devices. This implies that devices can be customised to align with an individual patient’s physique, which can boost treatment outcomes and enhance comfort during use. It has transformed the making of biomedical devices. In addition, the market growth is also influenced by the global spending in the healthcare sector is escalating rapidly, propelled by factors such as developments in technology, a rise in the incidence of chronic diseases, and an ageing population.
Restraints
Several issues are hindering the growth of the 3D printing medical devices market. This includes patent or legal problems, ethics, safety, material testing, cost, and sometimes material durability/robustness. This technology enables organizations or individuals to replicate or infringe upon the executive rights of other companies regarding their original designs without appropriate permissions. Even though this might result in legal issues and ramifications later, there are occasions when such actions could be viewed as warranted during urgent circumstances, which ultimately impedes the expansion of the market. Another factor causing obstruction is the cost. As of now, the cost of producing products through 3D printing continues to be relatively high for each unit.
Segment Analysis
By Product
- Medical Implants
- Orthopedic Implants
- Dental Implants
- Craniomaxillofacial Implants
- Prosthetics
- Tissue Engineering
- Surgical Instruments
- Surgical Guides
- Hearing & Audibility Aid
The surgical instruments segment is anticipated to thrive at a higher growth rate over the estimation period. The increasing need for minimally invasive procedures that utilise specialised surgical tools is a primary factor propelling the segment’s market share. In addition, researchers have leveraged 3D printing technology to fabricate these instruments characterised by intricate geometries and enhanced accuracy.
By Material
- Plastics
- Biomaterials
- Metal & Metal Alloys
- Ceramics
- Nylon
- Wax
The plastics segment is anticipated to capture a substantial portion of the 3D printing medical devices market throughout the forecast period. At present, 3D printed plastics are the most widely employed materials because of their versatility and cost efficiency. Moreover, with the rising demand for these plastic components, there is a growing necessity to understand their durability and strength. Apart from these, it is crucial to recognise that progress in 3D printing technology, along with techniques like annealing, coatings, and fiber reinforcement has greatly reduced the strength disparity between additive manufactured and injection-moulded components. This contributes to the expansion of the market size of the segment.
By Technology
- Laser Beam Melting (LBM)
- Electron Beam Melting (EBM)
- Droplet Deposition
- Photopolymerization
- Wax deposition Modelling
- Bio Printing
The electron beam melting (EBM) segment is expected to command this category of the 3D printing medical devices market and is likely to record a significant share over the estimation period. It is regarded as a new substitute for quick prototyping and production of metal components. This technology swiftly captures ground for its capability to provide completely dense parts, with qualities equivalent to wrought materials, at an expense and speed considerably lower than metal-based additive-fabrication techniques. In addition, it not only produces exceptional strength-to-weight ratios, decreases the expenditure on raw inputs and the component’s weight, but it paves the way for new design possibilities.
Regional Analysis
North America spearheads the 3D printing medical devices market and accounts for the biggest share among others. This supremacy is led by the United States and Canada owing to a mix of factors comprising considerable investments in research & development, a strong technological infrastructure and ecosystem, and robust industry adoption throughout several sectors such as healthcare and aerospace. Other segment drivers are a large pool of skilled talent, and government programs and initiatives in the field, especially in areas like advanced materials and manufacturing processes. Followed by Europe, which continues to move forward, with varied types of products to serve various consumer requirements.
Recent Market Development
· In November 2024, EOS introduced a new product called the P3 NEXT selective laser sintering (SLS) printer. EOS is a leading entity in Germany and the United States in additive manufacturing (AM) solutions. Moreover, this product was launched at an additive manufacturing event known as Formnext 2024 which took place in Frankfurt (Germany) from November 19 and 22, 2024. The company developed EOS P3 NEXT in direct response to customer input, leading to a printer that the company states offers greater productivity than the EOS P396, and at the same time, occupies less floor space due to its built-in monitor.
· In October 2024, WIMBA, a startup company in Poland, press released the launch of a newly established in-house 3D printing facility at its headquarters in Krakow to accelerate the production and distribution of its custom pet devices all over the world.
Browse full details of the report @ https://www.marketdataforecast.com/market-reports/medical-device-three-dimension-printing-market
ABOUT US
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
Contact Us
Market Data Forecast
www.marketdataforecast.com
Phone: +1-888-702-9626
Email: sales@marketdataforecast.com
